Underdog Pharmaceuticals, Inc., a pharmaceutical company designing engineered cyclodextrins to address atherosclerosis and other serious diseases of aging, has completed a partnership and technology acquisition agreement with MD.USE Innovative Solutions, SL.

Read more

Share Button

This website uses proprietary and third-party cookies. By continuing to navigate this website, you are accepting the use that we make of them. If you wish, you may change your settings on your browser.